[go: up one dir, main page]

BR9506234A - Unique enanciomeric compounds use the same processes to prepare the same and sodium salt of (+) - and (-) - 5-fluor-2 - (((4-cyclopropylmethoxy-2 -prinidinyl) meti) sulfinyl-1h-benzimidazole in its crystalline forms for the treatment of inflammatory gastrointestinal diseases and pharmaceutical preparation - Google Patents

Unique enanciomeric compounds use the same processes to prepare the same and sodium salt of (+) - and (-) - 5-fluor-2 - (((4-cyclopropylmethoxy-2 -prinidinyl) meti) sulfinyl-1h-benzimidazole in its crystalline forms for the treatment of inflammatory gastrointestinal diseases and pharmaceutical preparation

Info

Publication number
BR9506234A
BR9506234A BR9506234A BR9506234A BR9506234A BR 9506234 A BR9506234 A BR 9506234A BR 9506234 A BR9506234 A BR 9506234A BR 9506234 A BR9506234 A BR 9506234A BR 9506234 A BR9506234 A BR 9506234A
Authority
BR
Brazil
Prior art keywords
same
prinidinyl
enanciomeric
meti
cyclopropylmethoxy
Prior art date
Application number
BR9506234A
Other languages
Portuguese (pt)
Inventor
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Per Oskar Sverker Von Unge
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9506234A publication Critical patent/BR9506234A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9506234A 1994-05-27 1995-05-11 Unique enanciomeric compounds use the same processes to prepare the same and sodium salt of (+) - and (-) - 5-fluor-2 - (((4-cyclopropylmethoxy-2 -prinidinyl) meti) sulfinyl-1h-benzimidazole in its crystalline forms for the treatment of inflammatory gastrointestinal diseases and pharmaceutical preparation BR9506234A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400510 1994-05-27
PCT/SE1995/000518 WO1995032958A1 (en) 1994-05-27 1995-05-11 Novel substituted benzimidazoles

Publications (1)

Publication Number Publication Date
BR9506234A true BR9506234A (en) 1997-08-12

Family

ID=20392943

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9506234A BR9506234A (en) 1994-05-27 1995-05-11 Unique enanciomeric compounds use the same processes to prepare the same and sodium salt of (+) - and (-) - 5-fluor-2 - (((4-cyclopropylmethoxy-2 -prinidinyl) meti) sulfinyl-1h-benzimidazole in its crystalline forms for the treatment of inflammatory gastrointestinal diseases and pharmaceutical preparation

Country Status (16)

Country Link
EP (1) EP0712400A1 (en)
JP (1) JPH09504556A (en)
CN (1) CN1128998A (en)
AU (1) AU2632995A (en)
BR (1) BR9506234A (en)
CA (1) CA2166987A1 (en)
CZ (1) CZ21896A3 (en)
EE (1) EE9600010A (en)
FI (1) FI960366A0 (en)
IL (1) IL113603A0 (en)
IS (1) IS4320A (en)
MA (1) MA23562A1 (en)
PL (1) PL312691A1 (en)
TN (1) TNSN95063A1 (en)
WO (1) WO1995032958A1 (en)
ZA (1) ZA954129B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8804629D0 (en) * 1988-12-22 1988-12-22 Ab Haessle NEW THERAPEUTICALLY ACTIVE COMPOUNDS
DE4035455A1 (en) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab ENANTIOMER SEPARATION

Also Published As

Publication number Publication date
IS4320A (en) 1996-01-17
CZ21896A3 (en) 1996-06-12
JPH09504556A (en) 1997-05-06
AU2632995A (en) 1995-12-21
FI960366A7 (en) 1996-01-26
FI960366L (en) 1996-01-26
CN1128998A (en) 1996-08-14
PL312691A1 (en) 1996-05-13
WO1995032958A1 (en) 1995-12-07
TNSN95063A1 (en) 1996-02-06
ZA954129B (en) 1995-11-27
MA23562A1 (en) 1995-12-31
CA2166987A1 (en) 1995-12-07
FI960366A0 (en) 1996-01-26
EP0712400A1 (en) 1996-05-22
IL113603A0 (en) 1995-08-31
EE9600010A (en) 1996-04-15

Similar Documents

Publication Publication Date Title
BR9506561A (en) Homogeneous co-granule detergent composition detergent tablet processes for their preparation and use
CY2007001I1 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
BR9610248A (en) Compound pharmaceutical composition processes for the treatment of pain and for the preparation of a compound and use of the compound
FI19991869A7 (en) N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines and their use as pharmaceuticals
IT1162842B (en) TOPICAL PHARMACEUTICAL COMPOSITION FOR OPHTHALMIC USE AND ITS APPLICATION
BR9711098B1 (en) heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
DE69319320D1 (en) Pharmaceutical preparation with late onset continuous release
KR950703566A (en) Thienodiazepine compound and its pharmaceutical use [THIENODIAZEPINE COMPOUND AND MEDICINAL USE THEREOF]
BR9502797A (en) Insulin-protamine analog complexes and parenteral pharmaceutical formulations for the preparation of said analogues and pharmaceutical formulations and insulin-protamine crystals
BR9203032A (en) SPONGEOUS SLOW RELEASE MATERIAL, PROCESS TO PREPARE THE SAME, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC PROCESS
DE69001759D1 (en) ANTI-EMBLEM FILTER FOR LUNG AND KIT TO STORE AND USE THIS FILTER.
AT399878B (en) CRYSTALLINE CEPHALOSPORINE SALT AND THIS CONTAINING PHARMACEUTICAL AGENT
FI863971A7 (en) Pharmaceutical composition for use in the treatment of leukopenia.
BR9610733A (en) Compound processes for the preparation of it and for the treatment of a mammal pharmaceutical composition and use of a compound
IT8922164A0 (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION
FI911615A7 (en) New 4-quinolyl-dihydropyridines, methods for their preparation and their use in pharmaceuticals
IT8948430A0 (en) TRIPEPTIDE COMPOUNDS AND THEIR PHARMACEUTICAL USE AS IMMUNO-MODULATORS
BR9611234A (en) Compound pharmaceutical formulation use of the compound and processes for treating a pain and for preparing compounds
BR9608896A (en) Oxazolidinone derivatives their preparation and therapeutic use
FI903214A7 (en) Naphthylamino- and naphthyloxy-pyrimidines and related compounds, process for their preparation and their use as dermatological drugs
MX9100742A (en) PHARMACEUTICAL COMPOSITION AND PROCEDURE FOR ITS PREPARATION
BR9506234A (en) Unique enanciomeric compounds use the same processes to prepare the same and sodium salt of (+) - and (-) - 5-fluor-2 - (((4-cyclopropylmethoxy-2 -prinidinyl) meti) sulfinyl-1h-benzimidazole in its crystalline forms for the treatment of inflammatory gastrointestinal diseases and pharmaceutical preparation
PT82765A (en) PROCESS FOR THE PREPARATION OF ACTIVATING SUPPRESSOR FACTOR AND OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF AUTO-IMINES DISEASES
FI956353L (en) Pharmaceutical preparations and their use, especially in the treatment of neurodegenerative diseases
FR2733418B1 (en) NEW COMBINATIONS COMPRISING (-) HYDROXYCITRATE AND INCLUDING IN PARTICULAR NEW THERAPEUTIC ACTIVITIES

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law